Jan‐Dirk Vermeij

The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial

Willeke F. Westendorp, Jan‐Dirk Vermeij, Elles Zock et al. · The Lancet · 2015 · 327 citations

Medicine, Preventive Medicine, Antimicrobial Stewardship +6

Disruptions of Anaerobic Gut Bacteria Are Associated with Stroke and Post-stroke Infection: a Prospective Case–Control Study

Bastiaan W. Haak, Willeke F. Westendorp, Tjitske S. R. van Engelen et al. · Translational Stroke Research · 2020 · 130 citations · Full text

Life Sciences, Microbiology, Medical Microbiology +16

Autonomic Dysfunction Precedes Development of Rheumatoid Arthritis: A Prospective Cohort Study

Frieda A. Koopman, Man Tang, Jan‐Dirk Vermeij et al. · EBioMedicine · 2016 · 123 citations · Full text

Life Sciences, Internal Medicine, Physiology +12

Antibiotic therapy for preventing infections in people with acute stroke

Jan‐Dirk Vermeij, Willeke F. Westendorp, Diederik W.J. Dippel et al. · Cochrane Database of Systematic Reviews · 2018 · 75 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Development and internal validation of a prediction rule for post-stroke infection and post-stroke pneumonia in acute stroke patients

Willeke F. Westendorp, Jan‐Dirk Vermeij, Nina A. Hilkens et al. · European Stroke Journal · 2018 · 62 citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +17